Corporate Compliance

AstraZeneca to appeal $215M verdict

Compliance Monitor, February 27, 2008

AstraZeneca plans to appeal a jury's decision to award $215 million to Alabama in a Medicaid pricing fraud lawsuit, according to CNNMoney.com.

In its February 21 decision, the jury said AstraZeneca must pay $40 million in compensatory damages and $175 million in punitive damages for alleged false and misleading reporting of drug prices reimbursed by the Alabama State Medicaid Agency.

AstraZeneca claims that the lawsuit was unfounded and errors that occurred during court proceedings should bring about the overturning of the verdict, according to CNNMoney.com.

AstraZeneca is one of 73 pharmaceutical companies sued by the Alabama Attorney General (AG) in 2005. Two other pharmaceutical companies settled with the AG.

Comments

0 comments on “AstraZeneca to appeal $215M verdict